Last updated 13 days ago

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

865 patients around the world

Available in Brazil, Argentina

Approximately 865 subjects (519 contezolid acefosamil/contezolid: 346 linezolid) will be enrolled with moderate or severe DFI that are confirmed or suspected to be due to a Gram-positive bacterial pathogen (MITT analysis set).

MicuRx

7Research sites

865Patients around the world

This study is for people with

Diabetes

Diabetic Foot

Requirements for the patient

From 18 Years

All Gender

Medical requirements

Sites

Fundación Sanatorio Güemes - CABA, Buenos Aires

Recruiting

Fco Acuña de Figueroa 1228

Clínica Privada Chutro SRL - Córdoba

Recruiting

Av. Colon 788, Córdoba

Nuevo Hospital San Roque - Córdoba

Recruiting

Bajada Pucara 1900, Córdoba

Instituto Médico Platense SA - La Plata

Recruiting

Boulevard 51 Nro 315, La Plata, Buenos Aires

Centro de Investigaciones Médicas Mar del Plata SRL

Recruiting

Av. Colón 3083, Mar del Plata, Buenos Aires

Hospital Ernesto Dornelles

Recruiting

Av. Ipiranga, 1801 - Azenha, Porto Alegre - RS, 90160-092

CPClin – Centro de Pesquisas Clinicas LTDA

Recruiting

Avenida Angélica, 2162 – Consolação – São Paulo, SP, CEP:01228-200

SponsorMicuRx

Conditions

Diabetic Foot

Requirements

From 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05369052